JunHe Assists Biokin in M88 game APK Largest A-Share Equity Financing in M88 game APK Healthcare Sector Since M88 game APK Implementation of M88 game APK Registration-Based IPO System

On September 18, 2025, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin, 688506.SH) disclosed its report on M88 game APK issuance of shares to specific targets. M88 game APK total amount of funds raised was RMB 3.764 billion, and JunHe served as M88 game APK issuer's legal counsel for this project. All M88 game APK funds raised will be used for innovative drug research and development projects, which will help Biokin expand M88 game APK depth and breadth of its product pipeline under development, consolidate its competitive advantage in M88 game APK field of oncology treatment, and provide strong support for achieving M88 game APK company's strategic goals.

Deal Highlights

This transaction took 110 days from acceptance to registration, making it M88 game APK largest A-share equity financing project in M88 game APK healthcare industry since M88 game APK implementation of M88 game APK comprehensive registration system. It was an A-share refinancing project with M88 game APK smallest discount rate in M88 game APK healthcare industry this year.

Biokin was established in 2006 in Chengdu, Sichuan Province, China, and was listed on M88 game APK STAR Market in January 2023. It is a comprehensive biopharmaceutical company focused on biomedicine and addressing unmet clinical needs, and it has capabilities in early global research and development, global clinical development, large-scale production and commercialization. Biokin has established R&D centers in both China and M88 game APK United States and has built core technology platforms such as M88 game APK innovative ADC drug development platform (HIRE-ADC platform) and M88 game APK multi-specific antibody development platform (GNC platform), while developing a pipeline of advanced drugs. It also has business segments in chemical drug and traditional Chinese medicine formulations, forming full industry chain operation capabilities. Biokin has a strategy of being "rooted in China, going global and becoming a multinational pharmaceutical company (MNC)" and is committed to maintaining its leading advantage in M88 game APK field of oncology drugs.

JunHe has provided legal services to Biokin since 2020, including its listing on M88 game APK STAR Market, and serves as M88 game APK company's legal advisor. In this transaction, JunHe acted as M88 game APK issuer's counsel, fully leveraging its professional service capabilities. With close cooperation from Biokin and oM88 game APKr intermediaries, JunHe completed M88 game APK demonstration of M88 game APK issuance plan, undertook legal due diligence, prepared M88 game APK application materials and responded to regulatory inquiries in a short time period. We assisted Biokin in successfully passing M88 game APK review of M88 game APK Shanghai Stock Exchange and completing M88 game APK registration with M88 game APK China Securities Regulatory Commission, taking only 110 days from acceptance to registration. JunHe's consistently rigorous and efficient work style, meticulous and dedicated service attitude, and professional and high-quality service won unanimous recognition and trust from Biokin and oM88 game APKr intermediaries.

M88 game APK partners leading this transaction werem88 casino review 煤炭、汽车、船舶、石油化工、医药、污水处理, , M88 login 2009年毕业于韩国国际法律经营大学，获法学硕士学位andM88 app 宣传碳中和理念. m88 live casinowas M88 game APK internal review partner.